Meis homeobox 2 (MEIS2) inhibits the proliferation and promotes apoptosis of thyroid cancer cell and through the NF-κB signaling pathway

References

• Henton M, Gaglio B, Cynkin L, et al. And small-scale implementation of a web-based prognostic tool-surveillance, epidemiology, and end results cancer survival calculator. JMIR Cancer. 2017;3(2):e9.
   PubMed Web of Science ®Google Scholar
• Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–2921.
   PubMed Web of Science ®Google Scholar
• Valderrabano P, Khazai L, Thompson ZJ, et al. Cancer Risk Stratification of Indeterminate Thyroid Nodules: a Cytological Approach. Thyroid. 2017;27(10):1277–1284.
   PubMed Web of Science ®Google Scholar
• Harari A, Singh RK. Increased rates of advanced thyroid cancer in California. J Surg Res. 2016;201(1):244–252.
   PubMed Web of Science ®Google Scholar
• Rajoria S, Suriano R, George AL, et al. Estrogen activity as a preventive and therapeutic target in thyroid cancer. Biomed Pharmacother. 2009;136(2):3311–3322.
   Google Scholar
• Shevchyk IV, Cobian BA, Martinez SR. Age-based disparities in the use of total thyroidectomy for papillary thyroid carcinoma. Clin Transl Oncol. 2014;5(10):1253–1259.
   Google Scholar
• Lin R-Y. Thyroid cancer stem cells. Nat Rev Endocrinol. 2011;7(10):609–616.
   PubMed Web of Science ®Google Scholar
• Lu L, Yang B, Xin L, et al. Construction of MEIS2 Knockout HEK293T Cell Line by CRISPR/Cas9 Technology. Chin J Cell Biol. 2015;37:535–541.
   Google Scholar
• Choe S-K, Vlachakis N, Sagerstrom CG. Meis family proteins are required for hindbrain development in the zebrafish. Development. 2002;129(3):585–595.
   PubMed Web of Science ®Google Scholar
• Geerts D, Revet I, Jorritsma G, et al. MEIS homeobox genes in neuroblastoma. Cancer Lett. 2005;228(1–2):43–50.
   PubMed Web of Science ®Google Scholar
• Paige SL, Thomas S, Stoick-Cooper CL, et al. A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell. 2012;151(1):221–232.
   PubMed Web of Science ®Google Scholar
• Agoston Z, Li N, Haslinger A, et al. Genetic and physical interaction of Meis2, Pax3 and Pax7 during dorsal midbrain development. BMC Developmental Biology. 2012;12(1):10.
   PubMedGoogle Scholar
• Agoston Z, Schulte D. Meis2 competes with the Groucho co-repressor Tle4 for binding to Otx2 and specifies tectal fate without induction of a secondary midbrain-hindbrain boundary organizer. Development. 2009;136(19):3311–3322.
   PubMed Web of Science ®Google Scholar
• Bessa J, Tavares MJ, Santos J, et al. meis1 regulates cyclin D1 and c-myc expression, and controls the proliferation of the multipotent cells in the early developing zebrafish eye. Development. 2008;135(5):799–803.
   PubMed Web of Science ®Google Scholar
• Zhang X. Meis homeoproteins directly regulate Pax6 during vertebrate lens morphogenesis. Genes Dev. 2002;16(16):2097–2107.
   PubMed Web of Science ®Google Scholar
• Chen JL, Li J, Kiriluk KJ, et al. Deregulation of a Hox protein regulatory network spanning prostate cancer initiation and progression. Clin Cancer Res. 2012;18(16):4291–4302.
   PubMed Web of Science ®Google Scholar
• Crijns AP, De Graeff P, Geerts D, et al. MEIS and PBX homeobox proteins in ovarian cancer. Eur J Cancer. 2007;43(17):2495–2505.
   PubMed Web of Science ®Google Scholar
• Zha Y, Xia Y, Ding J, Zha Y, Xia Y, Ding J, et al. MEIS2 is essential for neuroblastoma cell survival and proliferation by transcriptional control of M-phase progression. Cell Death Dis. 2014;5(9):e1417.
   PubMedGoogle Scholar
• Vriens MR, Moses W, Weng J, et al. Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer. 2011;117(2):259–267.
   PubMed Web of Science ®Google Scholar
• He Z, Wang X, Huang C, et al. The FENDRR/miR-214-3P/TET2 axis affects cell malignant activity via RASSF1A methylation in gastric cancer. Am J Transl Res. 2018;10(10):3211–3223.
   PubMed Web of Science ®Google Scholar
• Celik H, Akgul O, Yıldız BD, et al. Predictors of central lymph node metastasis in papillary thyroid cancer. Ann Ital Chir. 2017;88:193–197.
   PubMed Web of Science ®Google Scholar
• Boucai L, Falcone J, Ukena J, et al. Radioactive iodine–related clonal hematopoiesis in thyroid cancer is common and associated with decreased survival. J Clin Endocrinol Metab. 2018;103(11):4216–4223.
   PubMed Web of Science ®Google Scholar
• Wu W, Zhou Q, Zhao W, et al. Ginsenoside Rg3 inhibition of thyroid cancer metastasis is associated with alternation of actin skeleton. J Med Food. 2018;21(9):849–857.
   PubMed Web of Science ®Google Scholar
• Mousa SA, Glinsky GV, Lin H-Y, et al. Contributions of Thyroid Hormone to Cancer Metastasis. Biomedicines. 2018;6(3):89.
   PubMed Web of Science ®Google Scholar
• Lan XB, Zhang H. [An introduction of surgical update in 2015 American thyroid association management guidelines for adult patients with Thyroid Nodules and Differentiated Thyroid Cancer]. Zhejiang Med J. 2016;54:172–176.
   Google Scholar
• Zhang H, Zhang K, Ning L, et al. Clinical significance of eukaryotic translation initiation factor 5A2 in papillary thyroid cancer. Bioengineered. 2020;11(1):1325–1333.
   PubMed Web of Science ®Google Scholar
• Huang W, Cui X, Chen J, et al. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition. Oncotarget. 2016;7(38):62520–62532.
   PubMedGoogle Scholar
• Guo YH, Chen S, Sumo SJ. and the enzymes of NF-κB signaling pathway involved in type 2 diabetes. J Med Postgrad. 2011;24:538–541.
   Google Scholar
• Liu J-Y, Zeng Q-H, Cao P-G, et al. RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway. Br J Cancer. 2018;118(12):1617–1627.
   PubMed Web of Science ®Google Scholar
• Hongwei Zheng, Jinsong Yuan, Yanning Gao, Shujun Cheng, “Role of NF-κB activation in tumor development”. Carcinogenesis, Teratogenicity, and Mutagenesis. 2006;05:407–410.
   Google Scholar
• Xu Y-H, Li Z-L, Qiu S-F. IFN-γ induces gastric cancer cell proliferation and metastasis through upregulation of integrin β3-mediated NF-κB Signaling. Transl Oncol. 2018;11(1):182–192.
   PubMed Web of Science ®Google Scholar
• Fang R, Wang C, Jiang Q, et al. NEMO–IKKβ Are Essential for IRF3 and NF-κB Activation in the cGAS–STING Pathway. J Immunol. 2017;199(9):3222–3233.
   PubMed Web of Science ®Google Scholar